Monday, October 3, 2022 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

Directors of IMS Health are selling the company too cheaply through an unfair process to TPG Capital, for $5.2 billion or $22 a share, stockholders say in Delaware Chancery Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...